To ask the Scottish Executive whether it is aware of the statement by Richard P Bentall, winner of the Psychological Society Book Award 2004, in his book, Madness Explained: Psychosis and Human Nature, that “the overzealous use of neuroleptic medication has led to a worldwide epidemic of avoidable iatrogenic illness, causing unnecessary distress to countless vulnerable people, and no doubt sending some to early graves” and what its position is on this statement.
Neuroleptic medication is defined as any drug that induces an altered state of consciousness, such as an antipsychotic drug. Iatrogenic illness is defined as any complication related to diagnosis and treatment of disease, regardless of whether the condition occurs as a known risk of a procedure or through errors of omission or commission.
Psychological therapies, rehabilitation and support have been effective in improving social functioning in patients and are used in conjunction with medication to improve overall quality of life.
It is important to note that serious side effects are uncommon and there is no evidence for a world wide epidemic of iatrogenic illness directly related to antipsychotic prescribing. People with schizophrenia have an increased risk of mortality due to cancer, and cardiovascular and endocrine conditions. However, there are complex reasons for this, some related to smoking, lack of exercise, poor attendance at screening and keep well clinics in primary care, poor diet, high risk behaviours and possibly the illness itself.
Whilst there is some uncertainty about the precise relationship between schizophrenia, metabolic problems and antipsychotic medication there is agreement that routine physical health screening of people prescribed antipsychotic drugs is required. This issue is picked up in the NICE (2009) Guidance which makes specific monitoring recommendations. Scotland has further addressed this issue in Improving the Physical Health and Wellbeing of those Experiencing Mental Illness December 2008 published by the Scottish Government, the SIGN guideline for schizophrenia published October 1998 and the Integrated Care Pathway for Schizophrenia published December 2007 which provides standards for care and monitoring of the disorder. The Quality of Outcomes Framework (QOF) in primary care is now trying to reduce these inequalities by specific screening programmes on physical health in severe mental illness.
It is also important to note that since the 1960s and the introduction of antipsychotic medication, there has been widespread closure of asylums across the UK and Europe. This has been directly attributed to our ability to control the symptoms of psychotic disorders with medication. This has led to most patients being treated in the community rather than hospital.